首页> 美国政府科技报告 >Medical Research and Evaluation Facility (MREF) and Studies Supporting the Medical Chemical Defense Program. Respiratory Casualty Care Management in the Field Medical Environment
【24h】

Medical Research and Evaluation Facility (MREF) and Studies Supporting the Medical Chemical Defense Program. Respiratory Casualty Care Management in the Field Medical Environment

机译:医学研究和评估机构(mREF)和支持医学化学防御计划的研究。野战医疗环境中的呼吸伤员护理管理

获取原文

摘要

Task 97-48 was conducted in two phases: 1) develop a 72-hr anesthetized, ventilated respiratory casualty swine model and 2) assess treatment efficacy of a) 10-15 cm of water positive end expiratory pressure (PEEP) with 45 percent oxygen, b) Ibuprofen (IBU), and c) n-acetyl- cysteine (NAC). The early diagnostic capability for pulmonary edema (PE) using the impedance cardiograph was evaluated in Phase II. Phosgene (CG) was selected as the respiratory insult and exposures ranged from 250 to 1000 mg(mg/m(3) for 10 minutes. A CO exposure concentration of 450 m%mg/m(3) over a 10 nun exposure (4, 500 mg/min/m(3)), a challenge estimated to be lethal to 85 percent, was selected for evaluating treatment efficacies.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号